Company Quick10K Filing
MedEquities Realty Trust
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-25
10-Q 2018-09-30 Filed 2018-11-09
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-02-21
10-Q 2017-09-30 Filed 2017-11-07
10-Q 2017-06-30 Filed 2017-08-08
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-02-27
10-Q 2016-09-30 Filed 2016-11-10
8-K 2019-05-17
8-K 2019-05-15
8-K 2018-12-31
8-K 2018-11-30
8-K 2018-11-09
8-K 2018-11-09
8-K 2018-10-06
8-K 2018-08-08
8-K 2018-05-16
8-K 2018-05-10
8-K 2018-02-21
8-K 2018-02-07

MedEquities Realty Trust Financials

MRT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash12,2119,5097,8068,2407,26412,6405,9174,1725,8108,37017,411
Accounts Receivable
Inventory
PP&E472,547468,822465,270472,255508,405521,744517,519537,290540,917538,441535,023
Assets530,002519,753528,695536,578570,833581,603597,678628,342628,209632,789643,159
Accounts Payable
Long-Term Debt155,699163,741206,782215,523232,065264,406270,447278,137284,553
Liabilities267,172161,495171,478180,677215,198224,850239,856271,982279,087285,429295,021
Stockholders' Equity260,521355,752354,788353,215352,791353,756354,890353,025345,529343,454344,254
Income Statement ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Revenue13,84514,01014,28214,82515,76616,23216,71617,5609,67813,30616,686
Cost of Revenue
Gross Profit
R&D
SG&A2,4362,8363,1712,9793,0462,4813,3165,0562,2844,690
Tax0-16-78-84
Net Income4,7345,3765,4755,7326,2666,6796,1544,186-1,1963622,103
Cash Flow ($'000)2016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-31
Cash Operating7,4928,98810,59710,60511,2137,8396,0597,618
Cash Investing-48-12,736-10,768-46,770-6,795-23,157-2,723-3,878
Cash Financing-10,1462,04560535,1899588,595-1,6985,301